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SURFACE-ENHANCED RAMAN SPECTROSCOPY (SERS) FOR THE 
QUALITATIVE ANALYSIS OF SYNTHETIC PIPERAZINES 
 
JESSAMYN ROSE WARD 
 
ABSTRACT 
Designer drugs are some of the most commonly abused substances in the world 
(1). They are synthesized through slight chemical modifications of existing substances, 
evading the law while maintaining the desired effects of the pharmaceutical or illicit 
substance. These drugs are often marketed as “herbal” or “natural,” but are fully 
synthetic. Due to their constant, rapid emergence, there is a need for a rapid method of 
identification, both in the field as well as in the laboratory (1, 2).  
One group of these designer drugs are synthetic piperazines. Named for the 
piperazine ring found in their chemical structures, synthetic piperazines are central 
nervous system stimulants that have the reputation of mimicking the psychoactive effects 
of the illicit compounds amphetamine and 3, 4-methylenedioxymethampetamine 
(MDMA) (3). Over the past 10 years, synthetic piperazine cases submitted to forensic 
laboratories in the United States have greatly increased, including a 30-fold increase 
between 2007 and 2009 alone (4).   
 Surface enhanced Raman spectroscopy (SERS) was investigated as a method for 
the rapid qualitative analysis of synthetic piperazines. SERS is a type of vibrational 
spectroscopy, which utilizes the interaction of light and matter to elucidate details of the 
vi 
chemical structure of a molecule. SERS combines laser spectroscopy with the optical 
properties of metallic nanostructures, resulting in strongly enhanced signals from the 
Raman scattering of light. Each chemical structure will give a unique SERS spectrum and 
this, coupled with the minimal-to-no sample preparation and the portability of a SERS 
instrument, makes SERS a strong candidate for the identification of not only synthetic 
piperazines, but all designer drugs.  
 To evaluate the use of SERS for the qualitative analysis of synthetic piperazines, 
eight synthetic piperazines were adsorbed onto a SERS substrate. The interaction with the 
gold nanoparticles enhanced the Raman scattering for all eight of the synthetic 
piperazines and SERS spectra were obtained. All eight drugs were found to give a robust 
and reproducible signal, requiring a fewer number of scans, less laser power, and less 
time for analysis compared with traditional Raman spectroscopy. When compared with 
traditional Raman spectra, the synthetic piperazines demonstrated sensitivity 
enhancement factors of up to 108 using SERS.  
A partial least squares-discriminant analysis (PLS-DA) statistical model was built 
and used to evaluate the analytical sensitivity and specificity of the SERS method. The 
PLS-DA model helped determine a limit of detection of 10 µg/mL of BZP. All eight 
synthetic piperazines could be identified by the statistical model below an error rate of 
20% when compared to each other- a strong indication of a method with high specificity.  
Through this research, it has been demonstrated that SERS can be applied 
efficiently as a qualitative technique for the analysis of synthetic piperazines.  
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1. INTRODUCTION 
1.1 Synthetic Piperazines 
1.1.1 Synthetic Piperazines  
Synthetic, or designer drugs, are some of the most commonly abused substances 
in the world (1). Designer drugs are also referred to as novel psychoactive substances, 
which are synthesized through chemical modifications of illicit or pharmaceutical drugs 
that maintain desired effects but evade the law. These goals are achieved by altering the 
molecular structure slightly from illicit or pharmaceutical form. Often, consumers of 
designer drugs are young people in dance clubs, rave scenes, or music festivals, as 
psychoactive substances are believed to enhance these experiences. These compounds are 
most commonly purchased on the internet, where they are marketed as “legal highs” (1).     
Among these designer drugs is a class of compounds known as synthetic 
piperazines. Named for the piperazine ring found in their chemical structures (Figure 1), 
synthetic piperazines are central nervous system stimulants that have the reputation of 
mimicking the psychoactive effects of the illicit compounds amphetamine and 3,4-
methylenedioxymethampetamine (MDMA) by binding to serotonin receptors in the brain 
(3). These drugs are synthesized through the chemical modification of the pharmaceutical 
drug piperazine, which was originally marketed as an anthelminthic (4). Although 
synthetic piperazines are often marketed as “herbal” or “natural,” they are fully synthetic 
and are classified as derivatives of either 1-benzylpiperazine (BZP) or 1-phenylpiperazine 
(2). 
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Figure 1. Chemical structure of synthetic piperazines (5) 
 
BZP has been available on the internet since early 2000 where it has been sold as 
capsules, tablets and free powder under the name “A2” as the hydrochloride (HCl) form 
(3). It has also been sold under the names “Frenzy” and “Nemesis.” Consumption of 
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synthetic piperazines is often through oral administration or insufflation, although 
injection or smoking is possible (2).  Although BZP was permanently scheduled in March 
of 2004 as a Schedule I compound by the U.S. Department of Justice Drug Enforcement 
Administration, its use has increased over time; by 2008, BZP appeared on the list of top 
25 drugs reported to the National Forensic Laboratory Information System (NFLIS) (6). 
The number of BZP cases submitted to U.S. forensic laboratories grew from 437 in 2007 
to 13,822 in 2009 (4). By 2010, 44 states reported synthetic piperazine cases to NFLIS, 
most being either BZP or 1-(3-trifluoromethylphenyl)-piperazine (TFMPP) (7).  
The U.S. is not the only country that has seen abuse of synthetic piperazines (8). 
BZP was first sold on an European internet website in 2000 (3). While the United States 
has mostly seen BZP and TFMPP in forensic casework, Europe has seen higher rates in 
the abuse of 1-(3-chlorophenyl)piperazine (mCPP). By 2006, the European Monitoring 
Center for Drugs and Drug Addiction (EMCDDA) estimated that 10% of illicit tablets 
sold in the European Union contained mCPP (8). In that year, 22 Member States of the 
European Union reported mCPP seizures to the EMCDDA, ranging from a six-tablet 
seizure in Luxembourg to approximately 145,000 tablets seized in one German case (8). 
Widespread abuse of synthetic piperazines has also been reported in New Zealand and 
Australia (9).   
As novel psychoactive substances, synthetic piperazines share common effects 
with stimulants such as amphetamine and MDMA, although BZP exhibits one-tenth the 
potency of amphetamine (4). These effects include euphoria, mood elevation, increased 
sociability and skin tingling. Higher doses of synthetic piperazines can have 
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hallucinogenic effects not present in lower doses. It is reported that MDMA-like effects 
are achieved by mixing BZP and TFMPP, and thus, these two compounds are often found 
combined in tablet form (4). Deaths have been reported with the use of BZP and TFMPP; 
however, most deaths were not the direct result of BZP or TFMPP toxicity, but by a loss 
in motor control, resulting in a fatal fall or traffic accident (10). 
In a study out of New Zealand, where BZP was unrestricted at the time, it was 
shown that BZP toxicity shows a wide array of adverse effects (9). Between April and 
September of 2005, 61 patients who presented in the Emergency Department on 80 
occasions had taken an average of 4.5 BZP tablets. The patients ranged in age from 15 to 
36 years old. Mild to moderate toxicity presented itself with symptoms such as insomnia, 
agitation, anxiety, nausea, vomiting, palpitations, dystonia and urinary retention. Some 
adverse effects lasted up to 24 hours. Severe and life-threatening toxicity was also 
observed. Fifteen patients experienced seizures and two patients had severe respiratory 
and metabolic acidosis. The authors concluded that BZP can cause severe and 
unpredictable toxicity and is also dangerous due to its narrow safety margin in dosing (9).       
 
1.1.2 Current Methods for the Qualitative Analysis of Synthetic Piperazines  
 Multiple difficulties arise with the analysis of novel psychoactive substances in 
forensic casework (11). First, there is difficulty obtaining information about current 
trends in drugs of abuse, as these trends are constantly changing. In order to have up-to-
date information, it is necessary to regularly check the internet for online suppliers and 
drug user forums for emerging trends. Second, the speed at which novel psychoactive 
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substances appear on the drug market leads to a lack of certified reference material 
needed for method development and validation. This, and the alarming rate at which 
novel psychoactive substances emerge, causes difficulty in developing methods of 
detection as fast as drugs are released on the market and abused by users. Many novel 
psychoactive substances are either not detected by the standard immunoassay reagents 
used for drug screening or generate misleading results. This is due to the similarities in 
chemical structure and common pharmacodynamics in the body between novel 
psychoactive substances and illicit drugs. For these reasons, clinical and forensic drug 
testing laboratories have turned to more laborious methods, such as mass spectroscopy, 
for detection of novel psychoactive substances (11).  
 Soon after synthetic piperazines were observed in forensic casework, there was a 
push for method development and validation (3). The earliest methods developed for the 
detection of synthetic piperazines involved labor-intensive liquid/liquid extractions (LLE) 
of synthetic piperazine powder, specifically from BZP capsules, using multiple reagents 
such as potassium hydroxide, sodium sulfate, and tert-butyl methyl ether. The use of 
immunoassays designed to detect amphetamine-like substances was evaluated first 
because BZP is believed to act on the same receptors in the brain as amphetamine (3). 
Two different amphetamine-like immunoassays were used: a fluorescence polarization 
immunoassay (FPIA) and an enzyme-multiplied immunoassay technique (EMIT). At a 
concentration of 100 µg/mL, BZP was not detected using FPIA technology, but did cross-
react when using EMIT. Gas chromatography (GC) with a nitrogen phosphorous detector 
(NPD) or a mass spectrometer (MS) were also evaluated. With both GC-NPD and GC-
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MS, BZP and TFMPP were unambiguously identifiable, both with and without 
derivatization (3). More recently, a high-pressure liquid chromatography with diode array 
detection (HPLC-DAD) method was developed and used to create a library of novel 
psychoactive substances data for forensic use. Among the different novel psychoactive 
substances detected, BZP, mCPP and 1-(4-methoxyphenyl)-piperazine (MeOPP) were 
recorded (12).  
 Although many of the methods mentioned, including GC-NPD, GC-MS and 
HPLC-DAD, can unambiguously identify different synthetic piperazines, these methods 
are labor-intensive, require multiple chemical reagents, and do not give rapid results. 
These methods would be adequate for use in a toxicology laboratory or in a drug 
chemistry laboratory after drugs have been seized. However, these methods could not be 
used in the field for rapid detection or be carried out by non-scientists. There is a critical 
need to rapidly identify novel psychoactive substances, including synthetic piperazines, 
in the field for multiples reasons. First, the number of drug-related Emergency 
Department visits in the United States doubled between 2004 and 2009 (13). A rapid, 
specific test that could be used by medical personnel would be critical for identifying the 
drugs a patient ingested so that the appropriate medical treatment could be administered. 
Another use for a rapid, easy-to-use method is for law enforcement. A portable method 
that could be kept in a law enforcement vehicle could help identify a driver under the 
influence of drugs, much like a breath analyzer, using the driver’s saliva. A non-invasive 
method is necessary for collection on the side of the road or other public locations. Law 
enforcement officials could also use a portable method for the identification of illicit 
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substances in different physical forms at the scene to determine if a drug arrest is 
warranted.  
  
1.2 Raman Spectroscopy and Surface Enhanced Raman Spectroscopy 
1.2.1 Raman Spectroscopy 
 Electromagnetic radiation, also known as light, can be physically described as 
both a wave and a particle (14). As a wave, light is characterized by either its wavelength, 
l, or its frequency, n. Together, these characteristics are used to determine the speed of 
light, c, which in Equation 1 is the speed of light in a vacuum, when light is at its fastest. 
When light enters any media, such as air or water, it travels slower than in a vacuum. 
(14). Light, as a wave, has oscillating electric and perpendicular polarized magnetic 
fields, which are both perpendicular to the direction of travel of the wave of light (Figure 
2). 
Equation 1. The speed of light.    𝒄 = 	𝝀𝝂 
 
Figure 2. The wave nature of light.  
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Light also behaves as a particle, which individually are called photons (14). The 
energy (E) of a single photon is proportional to the frequency of the wave and is 
described in Equation 2 using Planck’s constant, h. Equation 2 recognizes both the 
particle and wave nature of electromagnetic radiation. These physical characteristics of 
light are important to understand when discussing the theory behind many types of 
chemical instrumentation, including vibrational spectroscopy (14).  
Equation 2. Energy of a photon.    𝜠 = 	𝒉𝝂 
Vibrational spectroscopy is a field of science which studies interactions between 
electromagnetic radiation and the molecular motions of matter (15). The goal of these 
studies is often to elucidate details of the chemical structure of the matter. Vibrational 
spectroscopy is often utilized because it is easily performed, reproducible, and the results 
can be both qualitative and quantitative. Two common types of vibrational spectroscopy 
include Infrared (IR) spectroscopy and Raman spectroscopy (15). 
When a sample is irradiated with an electromagnetic light beam, this incident 
light can be transmitted, absorbed, or scattered through its interaction with the matter. IR 
spectroscopy measures the transmitted or absorbed light, whereas Raman spectroscopy 
analyzes the scattered light (16). Light can scatter in two different ways. Rayleigh, or 
elastic scattering, is light that scatters from the sample with the same frequency as the 
incident light. Photons that undergo Rayleigh scattering produce stronger signals than 
Raman because the vast majority of photons scatter elastically. Raman, or inelastic 
scattering, is light that scatters with a frequency higher or lower than the incident light. In 
Raman scattering, a change in the wavelength of the scattered radiation is observed  
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caused by the excitation or relaxation of molecular vibrational levels (17). Raman 
scattering produces a weaker signal than Rayleigh scattering because only a small portion 
of the photons (approximately 10-5%) from the incident light undergo Raman scattering 
(Figure 3) (18). In Raman spectroscopy, the vibrational frequency is measured as a shift 
from the incident light frequency, also known as the Raman shift. Each peak in a Raman 
spectrum is also called a band (16).  
 
Figure 3. Schematic representation of signals from Rayleigh and Raman scattering*.  
 
 Raman spectroscopy utilizes the ultraviolet-visible-near IR range of the 
electromagnetic radiation spectrum, which has frequencies in the 1014-1016 hertz (Hz, 
units of cycles per second) range. For this reason, it is easier to describe the frequency in 
                                                
* For Figure 3, the top of the peak due to Rayleigh scattering is not shown because, in reality, this band 
would be too tall in relation to the Raman band to be depicted accurately in this schematic. 
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terms of wavenumbers, which is the reciprocal of the wavelength (1/l) and has units of 
centimeters-1 (cm-1) (14). It is also preferable to use wavenumbers for describing 
vibrational spectra because these units, in contrast to wavelength, are directly 
proportional to energy.  
 
1.2.2 Surface-Enhanced Raman Spectroscopy  
Surface-enhanced Raman spectroscopy (SERS) is a vibrational spectroscopic 
technique that combines laser spectroscopy with the optical properties of metallic 
nanostructures, resulting in strongly increased Raman scattering signals (19). In 1977, 
Jeanmaire and Van Duyne first demonstrated that Raman scattering intensity can be 
greatly enhanced when the sample of interest is adsorbed on the surface of a 
nanostructured metal substrate (20). This surface enhancement effect, hence name SERS, 
results when the incident and scattered radiation is resonant with localized surface 
plasmon resonances (SPR) of the nanostructured surface. Hence, the laser light must be 
matched to the SPR of the SERS active substrate. When a molecule is in close proximity 
(< 5 nm) of the metal nanostructured surface, some of its Raman active vibrational modes 
are greatly enhanced in the Raman spectrum due to this SPR resonance, which effectively 
generates larger electromagnetic fields at the incident and scattered frequencies and, 
therefore, a greatly amplified signal is produced (17). In addition to this electromagnetic 
enhancement mechanism, there is also a weaker chemical enhancement mechanism that 
generally contributes to observed SERS intensities. The chemical enhancement occurs 
when there is a new charge-transfer state produced between the metal substrate and the 
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adsorbed molecule. This enhancement is specific to the site where the molecule adsorbs 
to the substrate. Raman scattering is more strongly enhanced for molecules closer to the 
metal substrate and for vibration modes that have polarization components perpendicular  
to the surface (17, 21). This orientation effect and chemical enhancement mechanism can 
lead to SERS spectra that have different relative intensities than normal Raman spectra. 
To obtain a SERS spectrum, the sample is loaded on the SERS substrate, which is 
generally made of silver or gold nanoparticles, and is placed under the microscope (16). 
A laser beam, which is the incident light, is passed through the objective lens of the 
microscope and focused onto the sample. At the sample, that light is either absorbed, 
transmitted, or scattered. The elastic, or Rayleigh, scattered light is filtered out by a high 
optical density notch filter, but the collected backscattered inelastic, or Raman light, is 
reflected by a series of mirrors to a monochromator where the dispersed light is read by a 
charge-coupled device detector (CCD). After the CCD, the electrical signal is amplified 
and converted into a spectrum by software on a computer. The resulting spectrum is 
plotted as the Raman shift in wavenumbers versus the signal intensity (Figure 4) (16).  
12 
 
Figure 4. The path of light in SERS.  
 
1.2.3 Current Uses of Raman Spectroscopy and SERS in Forensic Drug Chemistry 
 As Raman spectroscopy is a rapid test with little to no sample prep, it is an 
attractive method for application in the forensic field, specifically in forensic drug 
chemistry (18, 22). It has been most utilized for its ability to obtain many spectra in a 
short amount of time, thus allowing for many samples to be tested. One application of 
Raman spectroscopy in drug chemistry is called Raman spectral mapping, where Raman 
spectroscopy is used to test the homogeneity of bulk drug samples. By not only detecting 
drugs within a sample but also the different adulterants and diluents used, investigators 
can determine a common origin of bulk powder drug seizures. Different illicit drug 
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manufacturers will use different combinations and amounts of adulterants and diluents, so 
comparing these factors can help investigators trace drug distribution networks (18).  
 Portable Raman spectroscopy can also be used in situ to determine drugs in 
various matrices (22, 23). In one study, researchers were able to determine the presence 
of the common drug-facilitated sexual assault compound flunitrazepam in both alcoholic 
and non-alcoholic beverages. Even though bands were always present in the spectra that 
were caused by the beverage matrix, five characteristic marker bands used to identify 
flunitrazepam were present in different types of alcoholic beverages with ethanol 
concentrations up to 40% (23).  
 More recently, the use of SERS over traditional Raman spectroscopy has been 
investigated for use in drug chemistry and toxicological studies (13, 24, 25).  SERS is 
sometimes preferred over IR spectroscopy because aqueous solutions can be analyzed; 
this can be difficult in IR spectroscopy because aqueous solutions have strong water 
absorption bands in the spectrum. SERS is often preferred over Raman spectroscopy 
because of its increased sensitivity and the lack of interference from fluorescence, a 
problem that often presents with normal Raman spectroscopy (13, 24, 25).  
 As is helpful for many types of chemical instrumentation including GC-MS and 
IR spectroscopy, there is a push in the field of drug chemistry to build a SERS spectral 
library (13). As each molecule possesses a unique SERS spectrum, drugs could 
potentially be identified by matching an unknown spectrum with a known drug spectrum 
from a library. In 2011, Farquharson and colleagues built a SERS spectral library of over 
152 different prescription, over the counter, and illicit drugs, as well as drug metabolites. 
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Among these 152 drugs, the SERS spectrum of BZP was recorded. No other synthetic 
piperazine has been analyzed using SERS. These spectra were obtained using SERS-
active capillaries, which consist of gold colloids immobilized within a sol-gel matrix and 
are contained in glass capillary tubes. After a SERS library was built, the researchers 
spiked drugs in saliva samples and attempted to identify the drugs using a portable SERS 
instrument. This involved a solid-phase extraction (SPE) step prior to analysis (13). 
 While SERS has advanced into the field of drug chemistry, most methods involve 
sol-gel capillaries, which are not as portable or user-friendly as would be desired for field 
application. This would also be more difficult for instruments used by non-scientists. It 
was the desire of researchers that future work would develop a simple “lab-on-a-chip” 
SERS method capable of use by scientists, medical personnel, and law enforcement 
officials alike (13).    
 
1.3 Density Functional Theory 
 Although Raman spectroscopy, and thus, SERS, are extremely useful tools in the 
determining information about the structure of a molecule, assignment of the vibrational 
modes that produce Raman bands can be complicated (21). Theoretical calculations can 
help determine which vibrational modes will give rise to certain bands within a Raman or 
SERS spectrum. One such theoretical approach is the density functional theory (DFT) 
method. DFT is a computational chemistry method that utilizes quantum mechanical 
modeling to investigate the electronic structure of a system. The electronic structure of a 
system in DFT refers to both the location of electrons within a molecule, as well as 
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correlation of those electrons (26). In the field of forensic drug chemistry, the system in 
question would be a drug molecule (21).  
DFT calculations are carried out using the assumption that the energy of a 
molecule is a function of its electron density (25, 26). As electron density is also a 
function, the energy is known as a functional, which is a function of a function. Electron 
density is a function of three variables: the x-coordinate, y-coordinate, and z-coordinate 
of the electrons (Equation 3). Therefore, the energy of a molecule would be the function 
of this function, as displayed in Equation 4 (25, 26).  
Equation 3. Electron density function.  𝑬𝒍𝒆𝒄𝒕𝒓𝒐𝒏	𝒅𝒆𝒏𝒔𝒊𝒕𝒚 = 	𝒇(𝒙, 𝒚, 𝒛) 
 
Equation 4. Energy functional.                    𝑬𝒏𝒆𝒓𝒈𝒚 = 𝑭 𝒇(𝒙, 𝒚, 𝒛)  
 
As the mathematical functions used in DFT calculations are complex and involve 
a large number of variables, they are done using a computer with software designed for 
DFT calculations. In the first calculation, known as an optimization calculation, a 
molecular geometry is determined by minimizing the energy in respect to the electron 
density (Figure 5) (25).  
 
Figure 5. Results from an optimization calculation of BZP. Image produced in Gaussian 09 
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Next, in a vibrational frequency calculation, this molecular geometry is used to 
obtain the IR and Raman frequencies. These frequencies can be plotted as a theoretical or 
calculated spectrum, and in the software output, the vibration modes that correspond to 
each vibrational frequency can be pictured (Figure 6) (25).  
 
Figure 6. Result from the frequency calculation of BZP.  
 
DFT calculations, although not commonly used in forensic science, have been 
used to analyze experimental data and for spectroscopic study of the interactions between 
illicit drugs (25). DFT is a powerful tool when used in conjunction with experimental 
SERS data because it aids the scientists in obtaining a more fundamental understanding 
of why a spectrum contains particular bands. Being able to recognize these bands, 
especially when the chemical structure is of a drug molecule is unknown, can help 
categorize or preliminarily identify the unknown drug.  
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1.4 Partial Least Squares- Discriminant Analysis with Barcode 
 Chemometrics is a field of chemistry that studies the application of statistical 
analysis to chemical data (27). One common method used in chemometrics is partial least 
squares-discriminant analysis (PLS-DA). PLS-DA is a linear classification method that 
combines partial least squares regression with the discriminating power of a classification 
technique. It determines a mathematical model that is able to classify a sample to its 
appropriate category or class based on a set of measurements. In its application to 
spectroscopy, it can be further described as a qualitative method that defines a 
mathematical relationship between a spectrum (the independent variable) and a class (the 
dependent variable). Here, each class would represent one drug. A spectrum determined 
to be in that class would mean the spectrum was identified as that drug (27).   
In SERS, the application of PLS-DA allows known drug spectra to be inputs for 
the PLS-DA software to build a model that would identify a class for each drug 
represented in the spectral dataset. Then, the model could be used to classify an unknown 
spectrum and thus determine which drug the spectra is most likely from.  
 One important step during the construction of a PLS-DA model is cross-
validation. (28). Cross-validation involves a series of experiments, also called sub-
validation experiments. Each sub-validation experiment involves the removal of a subset 
of data from the total data set, construction of a PLS-DA model without the removed 
subset of data, and then the application of this model to the subset of data, testing that 
data as “unknowns.” This way, the model is built without the data that it then tests. The 
software takes the unknowns and determines if the PLS-DA model built during the sub-
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validation experiment can correctly classify the data. There are multiple types of cross-
validation methods; each has a different way of determining how the subset of data is 
selected. One type of cross-validation is the venetian blinds method. This method will 
have a number of data splits, s, that is input by the user.  Each subset of data is 
determined by selecting every sth object, therefore, a venetian blind cross-validation will 
have an s number of sub-validation experiments (28). Cross-validation serves two 
functions (27). First, it enables an assessment of the optimal complexity of a model, and 
second, it allows an estimation of the performance of a model when it is applied to 
unknown data. A model is considered “invalid” unless it is cross-validated (27). 
 “Barcode” is a spectral preprocessing, in-house written method coded in 
MATLAB (MathWorks, Natick, MA) that allows multivariate data analysis techniques, 
such as PLS-DA, to provide enhanced spectral classification (29). The barcode is based 
on the sign, positive or negative, of the second derivative of the SERS spectra as a 
function of Raman frequency. The spectrum is Fourier-filtered prior to this barcoding 
procedure in order to remove high frequency noise components. An upward curvature in 
the spectrum (positive second derivative) is assigned as a “+1” and a downward curvature 
(negative second derivative) is a “0” via this barcoding methodology. The result is that 
each spectrum is represented as a frequency-dependent binary “fingerprint.”  Once 
processed, the spectra look like barcodes (Figure 7). Without preprocessing using the 
barcode method, the PLS-DA model may misclassify spectra due to small variations in 
relative intensities or broad baseline differences. The use of barcoding SERS spectra 
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before use in a PLS-DA model has been demonstrated to increase specificity and 
reproducibility using this classification technique  (29).    
 
Figure 7. Visual representative of the Barcode used in PLS-DA with the synthetic piperazines.  
The raw spectra are in black; the barcodes are in color.  
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2. MATERIALS AND METHODS 
2.1 Synthetic Piperazines 
All synthetic piperazines were purchased from Cayman Chemical Company (Ann 
Arbor, Michigan) except for mCPP, which was purchased from Cerilliant Corporation 
(Round Rock, Texas). Derivatives of BZP used in this research are BZP itself, 1-(4-
fluorobenzyl)-piperazine (FBZP) and 4-methyl-1-benzylpiperazine (MBZP). Derivatives 
of 1-phenylpiperazine used in this research are MeOPP, 1-(para-fluorophenyl)-piperazine 
(pFPP), mCPP, 2,3-dichlorophenylpiperazine (DCPP) and TFMPP. 
For Raman spectral acquisition of synthetic piperazines in powder form, the 
powder was placed directly on a sodium chloride salt plate and placed in the instrument.  
For Raman spectral acquisition of synthetic piperazines in solution, solutions were 
prepared by dissolving approximately 4 milligrams (mg) of powder into 100 microliters 
(µL) of deionized water, resulting in approximately 40 mg/mL solutions. Since the 
synthetic piperazines were all in their HCl salt form, they were dissolved in water rather 
than methanol in order to achieve the most concentrated solutions possible for normal 
Raman signal acquisition. The solutions were put into quartz glass tubes and their normal 
Raman spectra were obtained. 
For SERS spectral acquisition of synthetic piperazines, BZP and mCPP were 
purchased as 1.0 mg/mL solutions in methanol.  Solutions of the same concentration were 
made of the remaining synthetic piperazines. All SERS spectra were collected at this 
concentration unless otherwise noted.  
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2.2 Spectral Acquisition 
2.2.1 SERS Spectral Acquisition 
SERS analysis of synthetic piperazines was performed using a Renishaw Raman 
microscope (RM 2000, Gloucestershire, England) with a 785 nm diode laser (HPNIR785, 
Gloucestershire, England) and a Leica microscope attachment (Wetzlar, Germany). SERS 
spectra were collected over a spectral range of 300-1800 cm-1 using the 50x (0.75 
numerical aperture, NA) objective.  The laser illumination spot on all samples, which is 
the focused area of the excitation laser beam, measured approximately 2.5 µm by 25 µm. 
SERS spectra were collected using approximately 0.5 mW of laser power with a 10 
second scan time. The Raman instrument was frequency calibrated for all spectral 
acquisitions using a silicon wafer as a positive control. Data was collected using 
Renishaw Windows Based Raman Environment (WiRE) Version 1.3 software.  
The SERS substrates used in the qualitative analysis of synthetic piperazines were 
silicon dioxide (SiO2) chips covered in gold nanoparticles (Figure 8). They were 
produced by an in-situ growth procedure previously developed by this laboratory (30). 
The substrates have a surface that is approximately 3 millimeters (mm) in diameter and 
are covered in small aggregates of monodispersed gold nanoparticles, each approximately 
80 nm in diameter.  
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Figure 8.  SERS Substrates.  
One microliter of solution was pipetted on the SERS substrate, left to dry for 
approximately 5 minutes, and the spectra were then taken. Each SERS spectra reported is 
an average of 10 spectra, using two separate SERS substrates. Five spectra were taken 
from each substrate.   
 Spectral display was conducted using a in-house written code for MATLAB. Pre-
processing of the data included a spectral cut (400 cm-1-1800 cm-1) and normalization of 
the data, which divides each y-value by the highest y-value for that spectrum. This sets 
the intensity of the highest band equal to one and the other bands relative to this intensity.  
 
2.2.2 Raman Spectral Acquisition 
Raman synthetic piperazine analysis was performed using a Renishaw Raman 
microscope with a 785 nm diode laser and a Leica microscope attachment. Raman spectra 
were collected for both synthetic piperazines in powder form and in solution. The normal 
Raman spectra were taken to compare to SERS spectra as well as to estimate surface 
enhancement factors (EF). Data for all spectra was collected using Renishaw WiRE 
software. As the laser power for Raman spectral acquisition was much higher for Raman 
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than SERS, which can lead to greater background noise and artifacts, a background 
spectrum was obtained and subtracted from each spectrum. 
Raman spectra of synthetic piperazines in powder form were collected by placing 
approximately 2 mg of the synthetic piperazine powder on a salt plate and placing it 
under the microscope attachment. The spectra were recorded over a spectral range of 
300-3200 cm-1 using the 50x (0.75 NA) objective. The laser spot on the samples 
measured approximately 2.5 µm by 25 µm and the spectra were collected using 
approximately 17.5 mW of power with a 10 second scan time.  
Raman spectra of synthetic piperazines in solution were collected by placing 
approximately 100 µL of synthetic piperazines solution into a quartz tube and placing it 
under the microscope attachment.  Spectral data was collected over a spectral range of 
300-3200 cm-1 using the 20x (0.40 NA) objective. The laser spot on the samples 
measured approximately 7 µm by 55 µm and the spectra were collected using 
approximately 22.5 mW of power with a 180 second scan time.  
Due to its Schedule I status, BZP was only available as a 1.0 mg/mL solution and 
was not purchasable in powder form. This solution was not concentrated enough to 
produce a Raman signal, so Raman spectra, both in powder and solution, were not 
obtained for BZP.  
As no features of spectral significance were observed below 400 cm-1 or over 
1800 cm-1 for SERS spectra, only data from 400-1800 cm-1 is displayed here.   
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2.2.3 DFT Calculations and Theoretical Raman Spectral Acquisition 
DFT calculations were performed using Gaussian 09 (Gaussian, Incorporated, 
Wallingford, CT).  Calculations used a Becke, three-parameter, Yang-Lee-Parr (B3YLP) 
level of theory with a 6-31G* basis set. The level of theory and basis set are user-chosen 
metrics that determine how electron density and correlation is calculated and applied in 
the software. This combination of level of theory and basis set combination was chosen 
both because it provides a good balance between accuracy and computational time and 
because it had been previously published for DFT calculations of controlled substances 
(25). First, optimization calculations were performed to determine the equilibrium 
conformation of each synthetic piperazine. This is the physical geometry of the molecule 
at which it has the lowest energy. Frequency calculations were then performed to 
determine the theoretical Raman spectrum. The synthetic piperazine’s theoretical spectra 
were calculated for an excitation wavelength of 785 nm, which is the excitation 
wavelength of the laser used experimentally. The theoretical spectra were exported and 
processed using MATLAB in the same manner as all other spectra.  
To determine band assignments, that is, to determine what molecular vibrations 
cause which bands within a SERS spectrum, the Gaussian 09 output provides an 
animation showing molecular vibrational motions corresponding with each band in the 
theoretical spectrum. The animations were viewed for each band in the DFT spectra, the 
molecular vibrations were visually determined, and the corresponding bands determined 
within the SERS, Raman of powder and Raman of solutions spectra for each drug.  
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2.3 Statistical Analysis 
2.3.1 Enhancement Factors  
One common statistic used to estimate the enhancement of SERS signal relative 
to traditional Raman intensity per molecule is the enhancement factor (EF) (31).  The EFs 
were calculated for each synthetic piperazine by comparing the cross-sections at the most 
intense band of the SERS spectrum with its corresponding band in the Raman spectrum 
of that drug in solution. The cross-sections are based on the relative number of molecules 
within the focus of the laser, the intensities of the bands, the scan times and laser powers. 
The units for a cross-section is intensity, in counts, per molecule times laser power, in 
mW, times scan time, in seconds, which is demonstrated in Equation 5 (31).  
Equation 5. Calculation of a cross-section.   𝑪𝒓𝒐𝒔𝒔	𝒔𝒆𝒄𝒕𝒊𝒐𝒏 = 𝑪𝒐𝒖𝒏𝒕𝒔𝑴𝒐𝒍𝒆𝒄𝒖𝒍𝒆𝒔	×	𝒎𝑾	×	𝑺𝒆𝒄 
  
To determine the EF of a drug, the SERS cross section of the most intense band 
was compared with the cross section of the corresponding band in the Raman spectrum 
(Equation 6).  
Equation 6. Calculation of an enhancement factor.     𝑬𝑭 = 	𝑪𝒓𝒐𝒔𝒔	𝒔𝒆𝒄𝒕𝒊𝒐𝒏𝑺𝑬𝑹𝑺 𝑪𝒓𝒐𝒔𝒔	𝒔𝒆𝒄𝒕𝒊𝒐𝒏𝑹𝒂𝒎𝒂𝒏  
 
 For this research, the EF is considered only an estimation because it is difficult to 
determine the exact number of molecules within the focus of the laser. For the purposes 
of this estimation, it was assumed that the synthetic piperazine molecules were adsorbed 
in an even monolayer on the surface of the SERS substrate.  
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2.3.2 PLS-DA Model 
 Spectral statistical analysis was completed using a PLS-DA toolbox (Eigenvector 
Research Incorporated; Manson, Washington) for MATLAB after the spectra had been 
preprocessed using the barcode procedure (29). Ten spectra of each synthetic piperazine 
were fed into the model as the independent variables and eight classes were made, one for 
each drug. 
The model used a 700-1700 cm-1 spectral range, a Fourier-transforming factor of 
60, and 10 latent variables. The model was cross-validated using a venetian blind method 
with 20 data splits. These parameters were used because they were found to give the best 
model with the highest sensitivity and specificity of each class, along with the best 
sensitivity and specificity of the method when unknowns were introduced.  
It is important to note that the analytical sensitivity and specificity of a PLS-DA 
model is separate from the sensitivity and specificity of the SERS method used to build 
that model.  
 
2.3.3 Sensitivity  
  To determine the sensitivity of this SERS method, that is, how little drug needs to 
be present to be detected, serial dilutions were performed. Two separate series of 
dilutions of BZP were made in final concentration of 1000 µg/mL, 500 µg/mL, 100 
µg/mL, 50 µg/mL, 10 µg/mL, 5 µg/mL and 1 µg/mL. Five spectra were taken from each 
concentration in each dilution for a total of 10 spectra per concentration. All spectra were 
measured using the same SERS method as previously mentioned.  
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 One measure of sensitivity is the limit of detection (LOD). The LOD is the lowest 
concentration at which spectra can be correctly identified below a specified error rate. To 
determine the LOD, the 70 spectra (10 from each concentration) were fed into the PLS-
DA model as unknowns. The PLS-DA model classified each spectrum into one class to 
which they most probably belonged. A particular concentration was considered to be 
correctly identified if it had an error rate of less than or equal to 20%; this would mean 
that up to two out of the 10 spectra could be misclassified. This error rate was chosen 
because it is a common acceptable error rate used by the Scientific Working Group for 
the Analysis of Seized Drugs (SWGDRUG) and the Scientific Working Group for 
Forensic Toxicology (SWGTOX) when dealing with LOD (32). 
 
2.3.4 Specificity 
To determine the specificity of this SERS method, a blind, “unknown” test was 
performed. Solutions of each synthetic piperazine were prepared at a concentration of 1.0 
mg/mL. A third party randomized the solutions into numbered vials and the identity of 
each vial was kept unknown to the data collector. Ten spectra of each unknown drug 
were collected using the same SERS method as above.  
To determine the specificity of the method, the unknown spectra were fed into the 
PLS-DA model to be classified. Each spectrum was classified as one of the eight classes 
of the PLS-DA model. A drug, as a whole, was considered identifiable with this method 
if 80% or greater of the spectra were correctly classified. The data were held to a standard 
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error rate of equal to or less than 20%. This acceptable error rate was chosen because it 
was the error rate also used for the sensitivity of the method.  
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3.  RESULTS AND DISCUSSION 
3.1 SERS  
3.1.1 SERS Spectra 
Eight synthetic piperazines were measured by SERS using SiO2 chips covered in 
gold nanoparticles. The interaction with the gold nanoparticles enhanced the Raman 
scattering for all eight of the synthetic piperazines and SERS spectra were obtained 
(Figure 9).  Ten spectra of each drug were averaged to produce the final spectra, which is 
a relatively low number of scans to give such a high signal-to-noise ratio. All eight drugs 
were found to give a robust and repeatable signal using SERS.   
  
Figure 9. SERS spectra of eight synthetic piperazines 
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The spectra of the synthetic piperazines are mostly distinguishable by the eye, 
although they share some common bands due to their similarity in chemical structure. 
Two common bands present in the eight synthetic piperazines were observed at ~1000 
cm-1 and ~1600 cm-1; these are bands commonly found in many illicit drugs that are 
caused by molecular vibrations in the benzene ring (25). Most of the intense features in 
all spectra were between 700-1700 cm-1 (Figure 10).  
 
Figure 10. SERS spectrum of BZP.  
 
Some distinguishing spectral features between the different synthetic piperazines 
were noted between 700-900 cm-1 and 1100-1300 cm-1. These are important to note 
because they are the bands that could be used to distinguish between the synthetic 
piperazines. Unsurprisingly, drugs that were more similar in structure than others, such as 
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BZP and MBZP, which differ by a methyl group, had very similar spectra. By this logic, 
FBZP would also be expected to have a similar spectrum to BZP and MBZP, but it is 
actually quite different. This is most likely caused by differences between the 
electronegativity of the atoms within the molecule. The greater electronegativity, which 
is essentially how much an atom “pulls” on the electrons shared in the covalent bond of 
the fluorine atom, would cause a greater change in electron density. DCPP and mCPP 
differ by only one chlorine atom and have similar equilibrium structures, but their spectra 
are significantly different from one another, which further supports that the 
electronegativity of the constituent atoms or functional groups have a great effect on the 
resulting SERS spectrum.  
Overall, the eight synthetic piperazines were successful candidates for use with 
SERS. While it is known that aromatic compounds are generally more successful when 
using SERS than aliphatic compounds, the lone pair of electrons on the nitrogen in the 
piperazine ring is believed to be the key to SERS success in this case (17). As synthetic 
piperazines and most illicit drugs are aromatic compounds and often contain nitrogen 
groups with lone pairs of electrons, this suggests that other illicit drugs could be 
successful when using SERS for analysis due to this characteristic.  
 
3.1.2 SERS versus Raman of Synthetic Piperazines in Solution 
 To demonstrate the advantage SERS has over tradition Raman spectroscopy, the 
synthetic piperazines’ Raman spectra were also measured. To eliminate as many different 
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variables as possible, SERS spectra were compared to Raman spectra of synthetic 
piperazines in solution instead of powder form, as solutions were used in SERS. 
 While all SERS spectra were measured using drug concentrations of 1 mg/mL, 
those solutions were not concentrated enough to produce a signal with normal Raman 
spectroscopy. Solutions of each synthetic piperazine were prepared for Raman 
spectroscopy at concentrations of approximately 40 mg/mL. Viewing the overlapped 
SERS and normal Raman spectra, it is evident that SERS produces more intense spectra 
than normal Raman spectroscopy with more peaks and less noise, all while requiring less 
of the drug in the sample (Figure 11). Many bands observed in the SERS spectra of these 
compounds are not present in the corresponding normal Raman spectra, which would 
lead to lower discriminating power between spectra of different drugs via normal Raman 
spectroscopy.  
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Figure 11. SERS and Raman spectra of pFPP. 
 
It is important to note that not only did the concentration of the solution need to 
be 40 times greater with Raman than SERS, but the method had to be modified as well. 
To obtain a Raman spectrum with any detail, the laser power and scan time had to be 
increased (Table 1). A volume of approximately 100 µL was needed for Raman 
spectroscopy while only 1 µL was needed for SERS.  The increase in signal intensity 
with a decrease in time and required resources demonstrates the clear advantage SERS 
demonstrates over traditional Raman spectroscopy.  
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Table 1. Method differences between SERS and Raman of solutions 
Parameter SERS Raman of Solutions 
Concentration of Drug 1.0 mg/mL 40 mg/mL 
Volume Required 1 µL 100 µL 
Laser Power 0.5 mW 22.5 mW 
Scan Time 10 seconds 180 seconds  
 
Although the spectra being compared in Figure 11 are of the same drug, pFPP, the 
spectra are visibly different in band frequencies and relative intensities. This is expected 
for many reasons. As the interaction of the incident light with the gold produces a 
localized plasmon field, the drug molecule’s orientation and individual atoms’ 
proximities to the gold nanoparticles will cause shifts in frequency and intensity 
differences. For example, the largest difference that can be noted in the pFPP spectra is 
the largest SERS band at approximately 1600 cm-1. As will be discussed further in the 
DFT calculation results, this band is common to the synthetic piperazines and is due to 
molecular in-plane stretching vibrations in the benzene ring. This suggests that the 
vibrational modes in the benzene ring were either closer to the surface of the SERS 
substrate or had vibrational modes with polarization components perpendicular to the 
surface. It is not an issue that the SERS spectra are different from the Raman spectra 
because an unknown SERS spectrum would only be compared against a SERS library. 
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3.1.3 Raman of Synthetic Piperazines in Power Form 
 To determine if SERS would be advantageous over traditional Raman 
spectroscopy when analyzing a synthetic piperazine in solid dose form, Raman spectra of 
the synthetic piperazines available in powder (all but BZP) were acquired. In general, 
having a chemical in solid form would produce a signal strong enough for Raman 
spectroscopy. For Raman spectroscopy, the powders were placed on reusable salt plates. 
These salt plates would not be as feasible in field work as SERS substrates because they 
are costly, fragile and would need to be cleaned in between uses. In contrast, this lab’s 
method of producing SERS substrates costs only cents per substrate and the substrates 
can be disposed of once a sample has been analyzed. By not having to reuse a drug 
sample in multiple tests, this would help prevent the contamination of subsequent 
samples. Raman spectroscopy for the synthetic piperazine powders required more laser 
power than SERS (17.5 mW compared to 0.5 mW, respectively). In the field, a less 
powerful laser would be desired because it would require less battery power, meaning the 
portable instrument could last longer on a single charge. More powder was also required 
for Raman spectra to be obtained. SERS only required 1 µL of a 1.0 mg/mL solution, 
which is only 0.001 mg of powder; Raman required closer to 2 mg. While using as little 
drug as possible during analysis will always be advantageous, specific situations which 
would warrant such rationing for trace and residue analysis include if some of the sample 
was needed for further analysis, or if enough should be kept for the defense to do 
independent testing.  
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3.2 DFT Calculations and Band Assignments 
DFT calculations were performed for all eight synthetic piperazines to help assign 
the bands observed within the SERS spectra to particular vibrations within the molecule. 
Overall, the theoretical spectra generated by the DFT calculations were in close 
agreement with the experimental SERS spectra, especially for the most intense bands. 
The DFT theoretical spectra had many more bands than SERS, which is a phenomenon 
noted by researchers who have compared DFT theoretical spectra to experimental data 
(25).  
For all of the synthetic piperazines, the optimization calculation showed the 
molecule’s lowest energy geometry to be with a planar benzene ring, including any 
constituents, and the piperazine ring in a chair or boat conformation. For BZP, its lowest 
energy conformation was with a planar benzene ring and a piperazine ring in a chair 
conformation (Figure 12).  The other synthetic piperazines with planar benzene rings and 
piperazine rings in chair conformation were MBZP, mCPP, MeOPP, pFPP, and TFMPP. 
DCPP and FBZP instead showed boat conformations of their piperazine ring portion.    
 
Figure 12. Lowest energy conformation of BZP.  
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In the SERS spectrum of BZP, intense bands were observed at 810, 830, 996, 1023, 
1174, 1213, 1264, 1444, and 1581 cm-1. In the DFT-calculated spectrum, those bands 
were observed at 785, 798, 1015, 1028, 1163, 1237, 1259, 1463, and 1627 cm-1, 
respectively (Figure 13). 
 
Figure 13. Comparison of BZP spectra from SERS and DFT calculations 
 
In BZP, as well as the other synthetic piperazines, as the wavenumbers, and thus 
energy, increased, so did the difference between the observed and calculated vibrational 
frequencies. This is likely due to the fact that the DFT calculations are performed using a 
variational method, and thus calculated energies are expected to be greater than or equal 
to physical energies (25). Additional differences may arise because the calculations are 
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performed assuming that the molecule is in the gas phase, where the SERS spectra were 
recorded from solutions (25). The DFT calculations were also run using the free base 
form of the molecule where experimentally, the HCl salt forms were used, which could 
also contribute to the differences between the DFT theoretical and observed normal 
Raman and SERS spectra. Lastly, the presence of the plasmonic field presents an 
additional perturbation to the energies and intensities in the SERS spectrum that is not 
easily accounted for in DFT calculations (25). 
Using the Gaussian 09 software, the bands were assigned to the movement of 
vibrational modes within different parts of the molecule. The three most intense SERS 
bands of BZP were at 996, 1023 and 1581 cm-1.  It was determined that these bands were 
mostly due to the bending and stretching of bonds within the benzene portion of the drug, 
designated in Table 2 as a subscript “C,” (Figure 14).  
 
 
Figure 14.  The letter designations used for the parts of the molecules. A is the piperazine ring and any 
of its constituents. B is the group of molecules that connect the piperazine ring to the benzene ring. C is the 
benzene ring and any of its constituents. 
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Table 2. Band assignments for BZP.  
SERS (cm-1) DFT (cm-1) Description† 
810 785 g(CH)C 
830 798 n(CC)B,  d(C=C-C)C 
996 1015 d(C=C-C)C 
1023 1028 na(CNC)A, dr(CH2)B, ns(C=C-C)C 
1174 1163 dt(CH2)B, n(CC)A, dt(CH2)A 
1213 1237 dt(CH2)A, dt(CH2)B, n(CN)B 
1264 1259 dt(CH2)A, dw(CH2)A, dw(CH2)B 
1444 1463 ds(CH2)B, ds(CH2)A 
1581 1627 na(C=C-C)C, d(CH)C 
 
It is well known that benzene and its derivatives show bands around 1000 and 
1600 cm-1, which was also experimentally observed in all the synthetic piperazines (33). 
What aids in the differentiation between these molecules are the effects of the atoms and 
bonds attached to the benzene ring, as these constituents change the electron density and 
mass distribution within the molecule, which influence the vibrational frequencies and 
intensities of the SERS spectrum.  
These constituents could provide the vibrational modes that give rise to 
characteristic vibrational maker bands. Characteristic marker bands would be bands 
observed in a SERS spectrum that would be unique to that molecule when compared to 
SERS spectra of similar molecules. In the case of the synthetic piperazines, most 
                                                
†  n, stretching; na, asymmetric stretching; ns, symmetric stretching; nb, ring breathing; d, bending; g, out-of-
plane bending, ds, scissoring; dw, wagging; dt, twisting; dr, rocking; A, piperazine ring; B, between rings; C, 
benzene ring. These notations will be used for all band assignment tables.  
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displayed a doublet band around 1000 cm-1 where the band at a higher wavenumber was 
significantly less intense than the band at the lower wavenumber. In the DFT and SERS 
spectra of DCPP, however, the two bands were slightly farther from each other and much 
closer in intensity (Figure 15). For this reason, it could be proposed that the band 
observed at 1055 cm-1 in the SERS spectrum of DCPP and the corresponding band at 
1083 cm-1 in the DFT spectrum could be a characteristic vibrational marker band for 
DCPP (Table 3).  
 
 
Figure 15. All DCPP spectra.   
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Table 3. Band assignments for DCPP‡ 
	
 
	 	 	 	 	
SERS 
(cm-1) 
Raman-
Solution 
(cm-1) 
Raman-
Powder 
(cm-1) 
DFT 
(cm-1)  
Description 
475 468 469 467 d(CCl)C, n(CCl)C d(CNC)A 
503  504 517 g(C=C-C)C, d(CCl)C 
1010 1019 1042 1058 d(C=C-C)C, n(CCl)C 
1055 1061 1057 1083 nb (C=C-C)C, n(CCl)C, dr(CH2)A 
1191  1155 1198 d(CH)C, na(CNC)A, dr(CH2)A 
1220  1193 1281 dt(CH2)A 
1272 1256 1253 1315 na(C=C-C)C, d(CN)B, d(CH)C, d(CCl)C 
1361   1373 n(CN)B, dw(CH2)A, d(CH)C, dt(CH2)A 
1572   1612 na(C=C-C)C, d(CH)C, d(CN)B, 
d(CCl)C 
1608 1582 1578 1632 na(C=C-C)C, d(CH)C, d(CCl)C 
By analyzing the frequency calculation, it was determined that the dominant 
vibrations associated with the 1055 cm-1 SERS peak were the breathing of the benzene 
ring and stretching between the benzene ring and chlorine atoms (Figure 16).   
 
Figure 16. The DCPP vibrational mode at 1083 cm-1. 
                                                
‡ Not all corresponding bands from the SERS spectrum were present in the traditional Raman spectra. For 
this reason, there are some band locations that are purposefully left blank in the table because these bands 
did not exist in that spectrum.  
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3.3 Statistical Analysis 
3.3.1 Enhancement Factors 
 Using the cross sections from the largest band in the SERS spectrum and its 
corresponding band in the Raman spectrum of each synthetic piperazine, an EF was 
calculated for each drug (Table 4).  
DCPP had the lowest EF at 106 and mCPP, MeOPP, and TFMPP had the highest, 
which each demonstrated an EF of 108.  The Raman scattering from these three drugs, 
enhanced by the gold nanoparticle SERS substrates, was as great as eight orders of 
magnitude larger than the signal from Raman scattering without surface enhancement, 
taking into account all the parameters of the method. The range in EFs could be caused 
by the differences in molecular geometry between the synthetic piperazines, as it is 
known Raman scattering is more strongly enhanced for vibrational modes that have 
polarization components perpendicular to the surface (17, 21). In fact, the two drugs with 
their piperazine rings in a boat conformation, DCPP and FBZP, demonstrated lower EFs. 
 
Table 4. Enhancement factors of synthetic piperazines. 
Drug EF 
DCPP 106 
FBZP 107 
MBZP 107 
mCPP 108 
MeOPP 108 
pFPP 107 
TFMPP 108 
 
43 
 
3.3.2 PLS-DA Model 
Using ten spectra from each synthetic piperazine at a concentration of 1.0 mg/mL, 
a PLS-DA model was created (Figure 17). The model had eight classes, one for each 
synthetic piperazine. The model was cross-validated using the venetian blinds method, 
which allowed for an estimation of the performance of the model when it was applied to 
unknown data.  
 
Figure 17. PLS-DA prediction value plots.§ 
                                                
§ The 80 spectra were represented on the x-axis as sample value. For a sample to be predicted as belonging 
to a particular class (y-axis), it must be over the discriminating red line. For example, in the top left plot, 
Samples 1-10 are predicted to belong to Class 1, or BZP. 
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Two measures of strength of a PLS-DA model are sensitivity and specificity. 
Statistically speaking, sensitivity is defined as the true positive fraction (34). During 
cross-validation, the software randomly takes spectra, creates a model without these 
spectra, builds a model, then feeds them into the model as “unknowns.” A high 
sensitivity would mean that the unknowns were predicted to belong to a class and truly 
belonged to that class, thus being true positives. For example, if all ten spectra of BZP 
were chosen during cross-validation and tested as “unknowns,” a sensitivity of 100% 
would mean that all ten spectra were correctly classified as BZP. Specificity is 
statistically defined as the true negative fraction (34). During cross-validation, a high 
specificity would mean that if spectra were chosen and were determined not to belong to 
a particular class, that they truly did not belong in that class. For example, for the BZP 
class to have a high specificity, any spectra that were not BZP during cross-validation 
would have to not be classified incorrectly as BZP. In this model, all eight classes were 
determined to have 100% specificity and 100% sensitivity, meaning that all spectra were 
correctly classified during cross-validation. It is important to note that the analytical 
sensitivity and specificity of the PLS-DA model are different from the sensitivity and 
specificity of the SERS method, as discussed below.  
 
3.2.3 Sensitivity  
 The PLS-DA model was used to determine the sensitivity of the SERS method by 
determining the LOD. To determine the LOD, two serial dilutions of BZP were 
performed and five spectra from each concentration in each dilution were fed into the 
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PLS-DA model as unknowns. Although this method of determining the sensitivity is 
strict and could produce a higher limit of detection than other methods, the PLS-DA 
model was used because PLS-DA has the potential to be an algorithm used in a portable 
SERS instrument to rapidly identify novel psychoactive substances and other drugs.  
Visually, it appears that the SERS spectra of BZP maintain most of the 
characteristic bands throughout the dilution, although the signal-to-noise ratio decreases, 
which is expected (Figure 18). Around 10 µg/mL, certain spectral features change, 
including the bands observed between 800 and 900 cm-1 and a shift in the bands observed 
between approximately 1150 and 1250 cm-1.  
 
 
Figure 18. SERS spectra from BZP dilutions 
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 The LOD for BZP was determined to be 10 µg/mL. At this concentration, the 
error rate was 10%, which was considered acceptable. Below this concentration at 5 
µg/mL and 1 µg/mL, the error rate rose to 60% and 80%, respectively (Table 5).  
Table 5. Error rates from BZP dilutions.  
Concentration Error Rate 
1000 µg/mL 0% 
500 µg/mL 0% 
100 µg/mL 10% 
50 µg/mL 0% 
10 µg/mL 10% 
5 µg/mL 60% 
1 µg/mL 80% 
 
 Although a lower LOD is always desirable to demonstrate higher sensitivity, this 
is an adequate starting location. In a drug seizure, the analyst can control the amount of 
drug used during testing, so a lower LOD is not necessarily required.  The LOD would be 
more of a concern if this method was used for toxicological testing, as different drugs in 
biological fluids are often found in concentrations in the ng/mL range and even lower.  
 
3.2.4 Specificity 
In a blind test of all eight synthetic piperazines, ten spectra were taken of each 
drug and fed into the PLS-DA model to be classified. Of the eight synthetic piperazines 
tested, all were classified with an error rate below 20% (Table 6). Six of those eight drugs 
had an error rate of 0%. Overall, 78 of 80 spectra were correctly classified, which is a 
total error rate of 2.5%.  
47 
Table 6.  Error rates from the blind test. 
Drug % Error 
BZP 0 
DCPP 10 
FBZP 0 
MBZP 0 
mCPP 0 
MeOPP 0 
pFPP 0 
TFMPP 10 
 
This high specificity demonstrates that while the spectra of each synthetic 
piperazine share common spectral features due to their similarities in chemical structure, 
they are easily distinguishable from one another using this PLS-DA statistical model.   
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4.  CONCLUSIONS 
4.1 Future Direction 
 This research is only the beginning for the detection of synthetic piperazines using 
SERS and there are many different directions in which the research could go. 
 First, the synthetic piperazines were only measured using non-portable 
instrumentation. These drugs should be tested using the same substrates and method 
parameters, but on a portable instrument. It would be important to note if synthetic 
piperazines are as successful on a portable instrument and if any parameters would need 
to be adjusted.  
The issue of sensitivity should be addressed for synthetic piperazines. Although, 
as mentioned, the LOD is not as crucial in drug chemistry as it is toxicology, SERS could 
have many applications in the toxicology field and increasing the sensitivity of SERS 
with the use of synthetic piperazines would be beneficial. Increasing the sensitivity could 
be evaluated in different ways, such as adjusting the chemometrics applied to the data.  
Although this SERS method had high specificity using PLS-DA, these drugs were 
only researched in their pure form. As many novel psychoactive substances, including 
synthetic piperazines, are sold as mixtures, and it should be evaluated if individual 
synthetic piperazines can be identified when they are mixed with other synthetic 
piperazines, adulterants, diluents, or other drugs.  
Ultimately, this SERS method should be evaluated further for its application in 
the field of forensic toxicology. Driving under the influence of drugs is a major issue 
facing society and SERS has the potential to be as valuable as an alcohol breath analyzer 
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in determining if a driver is under the influence.  To use SERS for this purpose, oral fluid 
would first have to be analyzed by itself to determine what bands would be present from 
the matrix. Then, synthetic piperazines should be spiked into the oral fluid to determine if 
synthetic piperazines could be identified in oral fluid at various concentrations. 
 
4.2 Evaluation of the Method  
 Within this research, SERS consistently showed advantages over traditional 
Raman spectroscopy of synthetic piperazines in powder form or in solution. When 
visually comparing the spectra, Raman spectra showed lower signal-to-noise ratios, 
decreased band intensity and a loss of many spectral features (Figure 19).  
 
Figure 19. All mCPP spectra. 
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In comparison to other research using SERS to analyze drugs, this method 
demonstrated increased sensitivity, as this method required less drug, less laser power, 
and shorter scan times than many of the research published (13, 24, 25). This method also 
provided the “lab-on-a-chip” concept other researchers have discussed as part of their 
future work. 
 One difficulty that arose during this research was the production of SERS 
substrate chips. Although overall these chips showed good gold nanoparticle coating, 
sometimes a batch of chips would be made that were either over-coated or undercoated. 
This increased the time required for analysis because it took longer to locate the areas 
with the best coating under the microscope. The difference in coating between chip 
batches also led to ranging intensities for drug solutions of the same concentration. While 
this wasn’t a large concern for qualitative analysis, obtaining consistent intensities for the 
same concentration would be vital in quantitative analysis.  Data was still collected that 
demonstrated EFs as high as 108, which shows that these SERS substrates are more 
sensitive than many others being used when factoring in other method parameters (13).  
 Through the application of PLS-DA to the SERS spectra of synthetic piperazines, 
it was demonstrated that these drugs could be rapidly identified by a computer system, 
instead of needing to be identified visually by picking characteristic marker bands for 
each drug. This ease in identification would be important for the application of portable 
SERS or in the case where a non-scientist was performing the analysis.  
Through this research, it has been demonstrated that SERS can be applied 
efficiently as a qualitative technique for the analysis of synthetic piperazines. Its 
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efficiency comes from the requirement of minimal to no sample preparation, the small 
amounts of drug required to produce a spectrum, the low number of scans required to 
produce a high signal-to-noise ratio, and the low laser power needed.  
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APPENDIX A: 
 
Figure 20.  SERS Spectrum of DCPP 
 
Figure 21.  SERS Spectrum of FBZP 
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Figure 22.  SERS Spectrum of MBZP 
 
Figure 23.  SERS Spectrum of mCPP 
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Figure 24.  SERS Spectrum of MeOPP 
 
Figure 25.  SERS Spectrum of pFPP 
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Figure 26.  SERS Spectrum of TFMPP 
 
Figure 27. All MBZP spectra 
56 
 
Figure 28. All FBZP spectra  
 
 
Figure 29. All MeOPP spectra  
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Figure 30. All pFPP spectra  
 
Figure 31. All TFMPP spectra  
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Table 7. Band Assignments for FBZP. 
SERS Raman- 
Solution 
Raman-
Powder 
DFT  Description* 
446  450 475 d(CNC)A, d(C=C-C)C 
829 828 829 826 g(CH)C, dr(CH2)A 
853 859 858 867 nb(C=C-C)C, dr(CH2)A, n(CF)C 
1020 1018 1041 1007 n(CC)A, n(CN)A, d(CNC)A 
1159 1168 1167 1227 n(CC)B, dw(CH2)B,  d(CH)C, 
dt(CH2)A 
1220 1216 1223 1283 dt(CH2)A, dt(CH2)B 
1265  1253 1323 d(CH)C, dt(CH2)A, dw(CH2)B 
1452 1453 1448 1436 dw(CH2)A, dw(CH2)B, d(CNC), 
d(CH)C 
1596 1607 1602 1520 ds(CH2)A, d(NH)A 
* n, stretching; na, asymmetric stretching; ns, symmetric stretching; nb, ring breathing; d, 
bending; g, out-of-plane bending, ds, scissoring; dw, wagging; dt, twisting; dr, rocking; A, 
piperazine ring; B, between rings; C, benzene ring	
 
Table 8. Band assignments for mCPP. 
SERS Raman- 
Solution 
Raman-
Powder 
DFT  Description 
445   446 g(C=C-C)C 
683 683 678 690 g(C=C-C)C, d(CCl)C, dr(CH2)A 
808   820 g(NH), ns(CNC)A 
997 994 988 971 nb(C=C-C)C, ns(CNC)A, d(CCl)C 
1014 1018  1006 d(C=C-C)C, n(CCl)C 
1220   1221 dt(CH2)A, d(NH)A 
1248 1246 1259 1267 n(CN)B, dt(CH2)A, d(CH)C 
1575   1619 na(C=C-C)C, d(CH)C, d(CCl)C 
1607 1597 1595 1654 na(C=C-C)C, d(CH)C, d(CCl)C 
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Table 9. Band Assignments for MBZP 
SERS Raman- 
Solution 
Raman-
Powder 
DFT  Description* 
779 753 749 787 n(CN)A, d(CNC)A 
812 785 787 829 n(CC)B, d(C=C-C)C, d(CN)B 
851 826 825 867 g(CH)C  
996 1005 1001 1020 ns(C=C-C)C, dr(CH2)B,  
1024 1018 1031 1058 ns(C=C-C)C, d(CH)C 
1184  1182 1188 d(CNC)A, dt(CH2)A, dt(CH2)B 
1214 1217 1214 1227 n(CC)B, d(CH)C, dt(CH2), d(CH)C 
1262  1245 1296 dt(CH2)B, dt(CH2)C, d(CH)C 
1469 1467 1467 1480 d(CH3)A, ds(CH2)A 
1578  1585 1645 na(C=C-C)C, d(CH)C, d(CC)B 
1625 1611 1606 1666 na(C=C-C)C, d(CH)C, d(CC)B 
 
Table 10. Band Assignments for MeOPP 
SERS Raman- 
Solution 
Raman-
Powder 
DFT  Description 
418   412 g(CN)B, g(CO)C, d(CNC)A 
807 801 807 811 g(CH)C, d(C=C-C)C 
912   959 nb(C=C-C)C, g(NH)A, n(CN)A 
1015 1016 1013 1040 n(CC)A, ns(CNC)A 
1178 1187 1185 1218 d(OCH3)C, dt(CH2)A 
1219   1257 n(CN)B, dt(CH2)A, d(CH)C 
1257 1245 1250 1300 n(COC)C, d(CH)C, ns(C=C-C)C, dt(CH2)A 
1304   1376 dw(CH2)A, n(CN)B 
1331  1326 1395 dr(CH2)A, d(NH)A 
1586 1617 1604 1678 na(C=C-C)C, n(CO)C, d(CH)C, d(CH3)C 
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Table 11. Band Assignments for pFPP 
SERS Raman- 
Solution 
Raman-
Powder 
DFT  Description* 
438  432 485 dr(CH2)A, d(CN)A 
715   709 g(NH)C, dr(CH2)A, d(CN)B, d(C=C-C)C 
815 819 816 841 nb(C=C-C)C, n(CF)C, g(NH) 
1013 1050 1043 1075 nb(C=C-C)C, n(CC)A, d(CNC)A, ns(CNC)A 
1163 1167 1170 1169 dr(CH2)A, n(CN)B 
1219 1235 1228 1271 n(CN)B, nb(C=C-C)C, dt(CH2)A, n(CF)C 
1255   1292 n(CF)C, d(CH)C 
1496   1501 d(NH)A, ds(CH2)A 
1579  1600 1640 na(C=C-C)C, d(CH)C, d(CF)C 
1606 1607 1620 1678 na(C=C-C)C, d(CH)C, n(CF)C 
 
Table 12. Band Assignments for TFMPP 
SERS Raman- 
Solution 
Raman-
Powder 
DFT  Description* 
752 729 761 730 d(CF3)C, d(C=C-C)C, n(CN)B 
1002 998 1003 1011 ns(C=C-C)C 
1015 1017  1037 n(CC)A, ns(CNC)A, dw(CH2)A 
1239   1223 dt(CH2)A, d(CH)C, d(NH)A 
1257   1264 n(CN)B, d(CH)C, dt(CH2)A 
1324  1330 1366 dt(CH2)A, dw(CH2)A, g(NH)A 
1363   1393 n(CN)B, dt(CH2)A, n(CCF3)C 
1571  1601 1645 na(C=C-C)C, d(CH)C, n(CCH3)C 
1614 1615 1623 1665 na(C=C-C)C, d(CH)C, d(CCF3)C 
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